OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neural Transmission is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease	78
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?	77
Current perspectives on brain circuits involved in food addiction-like behaviors	61
Eye movement study in essential tremor patients and its clinical correlates	60
Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study	52
Facets of movement disorders– a tribute to Heinz Reichmann	50
Dopamine agonists in the treatment of Parkinson's disease: the show must go on	48
Proteinopathies: molecular mechanisms and diagnostic perspectives	48
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients	44
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study	44
Contrasting features between Tourette syndrome and secondary tic disorders	40
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers	38
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response:	38
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease	36
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	35
Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up	34
Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!	34
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	33
Olfaction in patients with Parkinson’s disease: a new threshold test analysis through turning points trajectories	33
Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease	33
Kindness in science does matter	33
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons	32
Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease	31
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer’s disease therapy	30
Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research	28

Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey	27
The language profile in multiple system atrophy: an exploratory study	26